Methotrexate

Small molecule

Approvedregulatory verdict

Evidence outlook

Approved: Rheumatoid Arthritis, Acute Lymphoblastic Leukemia

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Partial signal

Also approved (8)
US
  • Polyarticular Juvenile Idiopathic Arthritis Methotrexate Injection is indicated for the treatment of pediatric patients with polyarticular Juvenile Idiopathic Arthritis (pJIA).Outside this platform's coverageFDA label
  • Non-Hodgkin Lymphoma Methotrexate Injection is indicated for the treatment of adults and pediatric patients with non-Hodgkin lymphoma.FDA label
  • Osteosarcoma Methotrexate Injection is indicated for the treatment of adults and pediatric patients with osteosarcoma as part of a combination chemotherapy regimen.Outside this platform's coverageFDA label
  • Breast Cancer Methotrexate Injection is indicated for the treatment of adults with breast cancer as part of a combination chemotherapy regimen.FDA label
  • Squamous Cell Carcinoma of the Head and Neck Methotrexate Injection is indicated for the treatment of adults with squamous cell carcinoma of the head and neck as a single agent.FDA label
  • Gestational Trophoblastic Neoplasia Methotrexate Injection is indicated for the treatment of adults with gestational trophoblastic neoplasia (GTN) as part of a combination chemotherapy regimen.Outside this platform's coverageFDA label
  • Psoriasis Methotrexate Injection is indicated for the treatment of adults with severe psoriasis.FDA label
  • Treatment of adults with mycosis fungoidesOutside this platform's coverageFDA label
Product first approved 1959
Featured evidence outside this drug's tracked markets:NCT00002456 · Graft Versus Host Disease · Phase 3 · completed · ungraded

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

This page stands for the molecule. Studies that name only the molecule, and no branded product, are listed here and are marked as studies of the molecule. A study of a branded product is on that product's page.

Phase 3 (275)
Acute Lymphoblastic Leukemia
NCT03020030 · Dana-Farber Cancer Institute
2017-03-03 – 2034-11 · Acute Lymphoblastic Leukemia, Pediatric
What this study did
NCT03007147 · Children's Oncology Group
2017-08-08 – 2034-09-30 · Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T Acute Lymphoblastic Leukemia
What this study did
NCT03959085 · Children's Oncology Group
2019-10-31 – 2032-03-31 · B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Central Nervous System Leukemia, Mixed Phenotype Acute Leukemia, Testicular Leukemia
What this study did
NCT03643276 · Martin Schrappe
2018-07-15 – 2028-07-14 · Acute Lymphoblastic Leukemia, Pediatric
What this study did
NCT04530565 · National Cancer Institute (NCI)
2021-01-25 – 2028-07-01 · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
What this study did
NCT03150693 · Alliance for Clinical Trials in Oncology
2017-09-20 – 2028-04-01 · B Acute Lymphoblastic Leukemia
What this study did
NCT03914625 · National Cancer Institute (NCI)
2019-07-03 – 2027-09-30 · B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome
What this study did
NCT02112916 · National Cancer Institute (NCI)
2014-10-04 – 2027-09-16 · Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood Lymphoblastic Lymphoma, Ann Arbor Stage III Adult Lymphoblastic Lymphoma, Ann Arbor Stage III Childhood Lymphoblastic Lymphoma, Ann Arbor Stage IV Adult Lymphoblastic Lymphoma, Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma, Childhood T Acute Lymphoblastic Leukemia
What this study did
NCT02101853 · National Cancer Institute (NCI)
2014-12-17 – 2027-09-16 · Recurrent B Acute Lymphoblastic Leukemia
What this study did
NCT03589326 · Takeda
2018-10-04 – 2027-07-31 · Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
What this study did
NCT05457556 · Children's Oncology Group
2023-03-15 – 2027-07-07 · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome
What this study did
NCT02003222 · National Cancer Institute (NCI)
2014-05-19 – 2027-02-25 · Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
What this study did
NCT01190930 · Children's Oncology Group
2010-08-11 – 2026-03-31 · Acute Lymphoblastic Leukemia, Adult B Lymphoblastic Lymphoma, Ann Arbor Stage I B Lymphoblastic Lymphoma, Ann Arbor Stage II B Lymphoblastic Lymphoma, Childhood B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Childhood B Lymphoblastic Lymphoma, Down Syndrome, Hypodiploid B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive
What this study did
NCT02883049 · National Cancer Institute (NCI)
2012-02-29 – 2026-03-31 · B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Central Nervous System Leukemia, Testicular Leukemia
What this study did
NCT02611492 · Assistance Publique - Hôpitaux de Paris
2016-04 – 2025-12 · Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia
What this study did
NCT00408005 · National Cancer Institute (NCI)
2007-01-30 – 2025-03-31 · T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
What this study did
NCT02881086 · Goethe University
2016-08 – 2024-12 · Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
What this study did
NCT00557193 · Children's Oncology Group
2008-01-15 – 2024-06-30 · Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Childhood T Acute Lymphoblastic Leukemia
What this study did
NCT01117441 · University Hospital Schleswig-Holstein
2010-06 – 2021-12-31 · Leukemia
What this study did
NCT01951885 · Case Comprehensive Cancer Center
2014-07-07 – 2021-08-11 · Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Hodgkins Disease, Chronic Lymphocytic Leukemia, Multiple Myeloma
What this study did
NCT00671034 · Children's Oncology Group
2008-07-21 – 2021-03-31 · Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia
What this study did
NCT00075725 · Children's Oncology Group
2003-12-29 – 2021-03-31 · Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia
What this study did
NCT00103285 · Children's Oncology Group
2005-04-11 – 2021-03-31 · Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia
What this study did
NCT00707083 · Prince of Wales Hospital, Shatin, Hong Kong
2008-05-01 – 2020-03-01 · Leukemia
What this study did
NCT00400946 · Dana-Farber Cancer Institute
2005-04 – 2019-06 · Drug/Agent Toxicity by Tissue/Organ, Leukemia
What this study did
NCT00382109 · Children's Oncology Group
2007-03 – 2017-06-30 · B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
What this study did
NCT00381680 · Children's Oncology Group
2007-03 – 2016-03 · B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia
What this study did
NCT00137111 · St. Jude Children's Research Hospital
2000-07-08 – 2014-04 · Lymphoblastic Leukemia, Acute
What this study did
NCT00003437 · Medical Research Council
started 1997-01 · Leukemia
What this study did
NCT01188798 · St. Jude Children's Research Hospital
2010-09 – 2012-02 · Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Hodgkin's Disease, Myelodysplastic Syndrome
What this study did
NCT00430118 · University Hospital Schleswig-Holstein
2000-07 – 2012-01 · Leukemia
What this study did
NCT00967057 · Children's Cancer and Leukaemia Group
2002-10 – 2011-12 · Leukemia
What this study did
NCT00131027 · Japan Adult Leukemia Study Group
2002-09 – 2011-09 · Lymphoblastic Leukemia, Acute
What this study did
NCT00165178 · Dana-Farber Cancer Institute
2000-09 – 2011-05 · Acute Lymphoblastic Leukemia
What this study did
NCT00015873 · Dutch Childhood Oncology Group
1999-05 – 2009-12 · Leukemia
What this study did
NCT00005945 · Children's Oncology Group
2000-06 – 2008-06 · Leukemia
What this study did
NCT00003728 · European Organisation for Research and Treatment of Cancer - EORTC
1998-12 – 2008-05 · Leukemia, Lymphoma
What this study did
NCT00764907 · University Hospital, Motol
2002-11 – 2007-10 · Leukemia
What this study did
NCT00005596 · Children's Oncology Group
2000-04 – 2007-07 · Leukemia
What this study did
NCT00005585 · Children's Oncology Group
2000-04 – 2007-07 · Leukemia
What this study did
NCT00002744 · Children's Oncology Group
1996-05 – 2007-03 · Leukemia
What this study did
NCT00002514 · Eastern Cooperative Oncology Group
1993-05-07 – 2006-12 · Leukemia
What this study did
NCT00022737 · National Cancer Institute (NCI)
2002-10 – 2006-10 · Childhood Acute Lymphoblastic Leukemia in Remission, Recurrent Childhood Acute Lymphoblastic Leukemia
What this study did
NCT00613457 · Associazione Italiana Ematologia Oncologia Pediatrica
2000-09 – 2006-07 · Leukemia
What this study did
NCT00002816 · Children's Oncology Group
1996-12 – 2006-04 · Leukemia
What this study did
NCT00005603 · Children's Oncology Group
2000-03 – 2005-09 · Leukemia
What this study did
NCT01230983 · Children's Oncology Group
1996-06 – 2004-10 · Cardiac Toxicity, Leukemia, Lymphoma
What this study did
NCT00002700 · European Organisation for Research and Treatment of Cancer - EORTC
1995-08 – 2004-03 · Leukemia, Lymphoma
What this study did
NCT00187083 · St. Jude Children's Research Hospital
1997-02 – 2003-12 · Acute Lymphoblastic Leukemia
What this study did
NCT00019409 · National Institutes of Health Clinical Center (CC)
1999-10 – 2001-07 · Leukemia
What this study did
Phase 2/3 (36)
Acute Lymphoblastic Leukemia
NCT07072585 · Children's Oncology Group
2026-08-28 – 2035-09-01 · Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma, Stage IV T Lymphoblastic Leukemia/Lymphoma, T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
What this study did
NCT03117751 · St. Jude Children's Research Hospital
2017-03-29 – 2028-09-30 · Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma
What this study did
NCT03564704 · Nanfang Hospital, Southern Medical University
2016-02-14 – 2021-05-30 · Leukemia, Leukemia, Acute, Adult Lymphoblastic Lymphoma, Leukemia, Lymphoblastic, Leukemia, T Cell, Adult Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Lymphoblastic Leukemia
What this study did
NCT00720109 · National Cancer Institute (NCI)
2008-07-14 – 2020-03-31 · Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
What this study did
Rheumatoid Arthritis
NCT07627893 · Singapore General Hospital
2026-06-01 – 2030-06-30 · Rheumatoid Arthritis (RA)
What this study did
NCT04136262 · Guang'anmen Hospital of China Academy of Chinese Medical Sciences
2019-11-25 – 2022-12 · Rheumatoid Arthritis
What this study did
NCT03324412 · Guang'anmen Hospital of China Academy of Chinese Medical Sciences
2017-10-28 – 2019-09-30 · Rheumatoid Arthritis
What this study did
NCT03173040 · Cui xuejun
2018-07 – 2018-12 · Niu Bang Zi Pill, Rheumatoid Arthritis
What this study did
NCT02551575 · Guang'anmen Hospital of China Academy of Chinese Medical Sciences
2014-11 – 2017-12 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT07724457 · National Cancer Institute (NCI)
2027-07-27 – 2033-11-01 · Recurrent Burkitt Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements, Refractory Burkitt Lymphoma, Refractory High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
What this study did
NCT02205762 · North American Consortium for Histiocytosis
2016-11-02 – 2031-11 · Langerhans Cell Histiocytosis
What this study did
NCT07168980 · Children's Cancer Group, China
2025-07-01 – 2030-06-30 · Mature B-cell Non-Hodgkin Lymphoma
What this study did
NCT05691478 · National Cancer Institute (NCI)
2023-03-03 – 2030-03-20 · High Grade Osteosarcoma, Localized Osteosarcoma, Metastatic Osteosarcoma, Secondary Osteosarcoma
What this study did
NCT02405676 · Children's Cancer Group, China
2015-01-01 – 2029-12 · Mature B-cell Non-Hodgkin Lymphoma
What this study did
NCT07185373 · Huashan Hospital
2025-10-01 – 2029-07-30 · Primary Central Nervous System Lymphoma
What this study did
NCT07501507 · Centre Hospitalier Universitaire de Nice
2026-09-23 – 2028-02 · Erosive Hand Osteoarthritis
What this study did
NCT06719479 · SUNHO(China)BioPharmaceutical CO., Ltd.
2025-01-01 – 2028-01-01 · NPC, HNSCC, Recurrence, Metastasis
What this study did
NCT04628767 · National Cancer Institute (NCI)
2021-11-12 – 2027-09-30 · Renal Pelvis and Ureter Urothelial Carcinoma
What this study did
NCT07842796 · Benha University
2024-12-15 – 2026-12-12 · Ectopic Pregnancy
What this study did
NCT04453345 · Institute of Hematology & Blood Diseases Hospital, China
2013-05-20 – 2025-05-20 · T-LGL Leukemia, Clpd-Nk
What this study did
NCT05057130 · Blokhin's Russian Cancer Research Center
2022-01-10 – 2024-12 · Osteosarcoma, Neoplasms, Connective Tissue, Neoplasms, Connective and Soft Tissue, Sarcoma, Sarcoma of Bone
What this study did
NCT01228331 · Universitätsklinikum Hamburg-Eppendorf
2010-10 – 2024-11-20 · Leukemia
What this study did
NCT03885388 · Women's Hospital School Of Medicine Zhejiang University
2019-03-08 – 2023-12-31 · Gestational Trophoblastic Tumor, Effects of Chemotherapy, Drug Toxicity
What this study did
NCT04482543 · Shahid Beheshti University of Medical Sciences
2020-08-01 – 2021-09-01 · Proliferative Vitreoretinopathy
What this study did
NCT03516903 · University of Sao Paulo
2018-04-17 – 2020-12-17 · Myocardial Infarction, Anterior Wall, Myocardial Remodeling, Ventricular
What this study did
NCT03553238 · Nanfang Hospital, Southern Medical University
2016-02-14 – 2020-08-30 · Leukemia, Acute, Leukemia, T Cell, Leukemia, Lymphoblastic
What this study did
NCT03280979 · Assiut University
2017-10 – 2019-10 · Gestational Trophoblastic Disease
What this study did
NCT03217734 · Jeffrey J Crowley MD
2017-04-10 – 2018-12-31 · Psoriasis
What this study did
NCT02606539 · Maher elesawi kamel elesawi
2015-09 – 2017-08 · Gestational Trophoblastic Neoplasms
What this study did
NCT01788501 · Seoul National University Hospital
2011-11 – 2017-03-01 · Graft vs Host Disease
What this study did
NCT00002499 · Grupo Argentino de Tratamiento de la Leucemia Aguda
started 1990-01 · Leukemia
What this study did
NCT01087398 · Tehran University of Medical Sciences
2009-09 – 2012-12 · Osteopetrosis
What this study did
NCT00759811 · Instituto de Cardiologia do Rio Grande do Sul
2007-12 – 2008-11 · Heart Failure, Myocardial Ischemia
What this study did
NCT00014274 · European Organisation for Research and Treatment of Cancer - EORTC
2001-01 – 2008-03 · Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
What this study did
NCT00003187 · Virginia Commonwealth University
1995-05 – 2005-02 · Leukemia, Lymphoma, Myelodysplastic Syndromes
What this study did
NCT00035958 · Children's Hospital Medical Center, Cincinnati
2002-08 – 2002-08 · Dermatomyositis
What this study did
Phase 2 (503)
Acute Lymphoblastic Leukemia
NCT07227584 · Dana-Farber Cancer Institute
2026-04-03 – 2035-07-31 · Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Leukemia
What this study did
NCT06533748 · St. Jude Children's Research Hospital
2025-01-23 – 2034-05 · Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
What this study did
NCT06099366 · Hee Young Ju
2024-03-05 – 2033-12-31 · Lymphoblastic Leukemia in Children
What this study did
NCT06390319 · St. Jude Children's Research Hospital
2024-12-27 – 2033-12 · T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma, Mixed Phenotype Acute Leukemia
What this study did
NCT03286634 · National Hospital Organization Nagoya Medical Center
2017-04-18 – 2033-03-31 · Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer
What this study did
NCT07636564 · SWOG Cancer Research Network
2026-10-14 – 2032-04-16 · Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia
What this study did
NCT03970096 · Fred Hutchinson Cancer Center
2019-11-19 – 2030-12-31 · Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm
What this study did
NCT07643103 · Institute of Hematology & Blood Diseases Hospital, China
2026-06-12 – 2030-05-31 · Ph- Acute Lymphoblastic Leukemia (Ph-ALL)
What this study did
NCT05303792 · Alliance for Clinical Trials in Oncology
2023-06-09 – 2029-05 · B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
What this study did
NCT06918431 · City of Hope Medical Center
2025-10-10 – 2029-03-30 · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Lymphoblastic Lymphoma
What this study did
NCT04845035 · University of Michigan Rogel Cancer Center
2024-01 – 2029-01 · Acute Lymphoblastic Leukemia
What this study did
NCT07301138 · Ruijin Hospital
2025-12-15 – 2028-12-31 · Acute Lymphoblastic Leukemia
What this study did
NCT06317662 · National Cancer Institute (NCI)
2025-06-05 – 2028-12-31 · Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
What this study did
NCT02877303 · M.D. Anderson Cancer Center
2016-11-01 – 2028-11-01 · B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
What this study did
NCT00501826 · M.D. Anderson Cancer Center
2007-07-11 – 2028-10-31 · T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
What this study did
NCT04546399 · National Cancer Institute (NCI)
2020-12-17 – 2028-06-30 · Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
What this study did
NCT04747912 · University of Chicago
2021-03-02 – 2028-03-01 · Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia
What this study did
NCT05761171 · Children's Oncology Group
2024-01-08 – 2027-12-31 · Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage, Recurrent Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged, Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory Acute Leukemia of Ambiguous Lineage, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage, Refractory Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged, Refractory Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia, Refractory Mixed Phenotype Acute Leukemia
What this study did
NCT05660473 · Institute of Hematology & Blood Diseases Hospital, China
2022-08-01 – 2027-12-30 · Precursor Cell Lymphoblastic Leukemia-Lymphoma
What this study did
NCT04440267 · Institute of Hematology & Blood Diseases Hospital, China
2020-07-08 – 2027-12-20 · Acute Leukemia of Ambiguous Lineage
What this study did
NCT03263572 · M.D. Anderson Cancer Center
2017-11-29 – 2027-11-30 · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia, t(9;22)
What this study did
NCT01424982 · M.D. Anderson Cancer Center
2011-10-05 – 2027-10-31 · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Untreated Adult Acute Lymphoblastic Leukemia
What this study did
NCT01920737 · Memorial Sloan Kettering Cancer Center
2013-08-07 – 2027-08 · Leukemia
What this study did
NCT02143414 · National Cancer Institute (NCI)
2015-06-30 – 2027-06-06 · Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia
What this study did
NCT05519579 · Northside Hospital, Inc.
2023-06-30 – 2027-06-01 · Acute Lymphoblastic Leukemia
What this study did
NCT04329325 · Memorial Sloan Kettering Cancer Center
2020-03-30 – 2027-03 · Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive
What this study did
NCT03147612 · M.D. Anderson Cancer Center
2018-02-08 – 2027-02-28 · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia
What this study did
NCT00792948 · National Cancer Institute (NCI)
2009-09-01 – 2027-01-06 · Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Adult L1 Acute Lymphoblastic Leukemia, Adult L2 Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia
What this study did
NCT02981628 · Children's Oncology Group
2017-06-19 – 2026-12-31 · Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma, Refractory B Acute Lymphoblastic Leukemia, Refractory B Lymphoblastic Lymphoma
What this study did
NCT06210750 · National Cancer Institute (NCI)
2024-08-09 – 2026-09-22 · T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
What this study did
NCT02723994 · Incyte Corporation
2016-09-30 – 2026-03-03 · Leukemia
What this study did
NCT03913559 · St. Jude Children's Research Hospital
2019-05-14 – 2025-09-15 · Acute Lymphoblastic Leukemia
What this study did
NCT02220985 · Fred Hutchinson Cancer Center
2015-03-23 – 2025-05-01 · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Undifferentiated Leukemia, Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blastic Plasmacytoid Dendritic Cell Neoplasm, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Donor, Lymphoblastic Lymphoma, Myelodysplastic Syndrome With Excess Blasts, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission
What this study did
NCT02828358 · National Cancer Institute (NCI)
2017-04-01 – 2024-12-31 · Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia
What this study did
NCT00558519 · Alliance for Clinical Trials in Oncology
2008-03-12 – 2024-06-24 · Leukemia
What this study did
NCT00390793 · M.D. Anderson Cancer Center
2006-09-28 – 2024-02-02 · Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic Leukemia, t(9;22)
What this study did
NCT03602898 · Fred Hutchinson Cancer Center
2021-06-01 – 2023-09-17 · Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid System Neoplasm, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Recurrent Acute Myeloid Leukemia, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Refractory Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia
What this study did
NCT02776605 · PETHEMA Foundation
2016-06 – 2023-08 · ALL
What this study did
NCT01858740 · Fred Hutchinson Cancer Center
2014-04-10 – 2023-07-30 · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Adult Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic Leukemia
What this study did
NCT03860844 · Sanofi
2019-08-06 – 2023-05-26 · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
What this study did
NCT02339350 · The Korean Society of Pediatric Hematology Oncology
2015-01 – 2023-04 · Acute Lymphoblastic Leukemia, Child
What this study did
NCT02043587 · University of California, San Diego
2014-01 – 2022-04-14 · Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma
What this study did
NCT02523976 · Institute of Hematology & Blood Diseases Hospital, China
2015-08-01 – 2021-12-31 · Acute,Leukemia, Lymphoid
What this study did
NCT01256398 · National Cancer Institute (NCI)
2010-12-14 – 2021-11-15 · Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
What this study did
NCT01700946 · St. Jude Children's Research Hospital
2013-04-15 – 2021-07-24 · Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma
What this study did
NCT03518112 · M.D. Anderson Cancer Center
2018-04-18 – 2021-05-27 · Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia
What this study did
NCT02420717 · M.D. Anderson Cancer Center
2015-07-15 – 2021-01-20 · Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Refractory Ph-Like Acute Lymphoblastic Leukemia
What this study did
Phase 1/2 (72)
Acute Lymphoblastic Leukemia
NCT07387926 · Novartis Pharmaceuticals
2026-07-05 – 2036-05-30 · Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
What this study did
NCT05848687 · Tanja Andrea Gruber
2023-11-03 – 2033-12 · Lymphoblastic Leukemia
What this study did
NCT02553460 · St. Jude Children's Research Hospital
2016-01-29 – 2031-10 · Acute Lymphoblastic Leukemia
What this study did
NCT01371630 · M.D. Anderson Cancer Center
2011-08-26 – 2027-12-25 · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt-Like Lymphoma With 11q Aberration, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Burkitt Lymphoma, Refractory B Acute Lymphoblastic Leukemia, Refractory Burkitt Lymphoma
What this study did
NCT05192889 · St. Jude Children's Research Hospital
2022-08-25 – 2027-02 · Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia
What this study did
NCT06207123 · University of Chicago
2024-09-13 – 2026-12-01 · Acute Leukemia, Lymphoblastic Leukemia, Lymphoblastic Lymphoma
What this study did
NCT03808610 · M.D. Anderson Cancer Center
2019-04-03 – 2026-05-05 · Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Refractory T Acute Lymphoblastic Leukemia
What this study did
NCT03817320 · Therapeutic Advances in Childhood Leukemia Consortium
2019-02-12 – 2025-06-30 · ALL, Childhood, Lymphoblastic Lymphoma, Childhood, Lymphoblastic Leukemia, Acute, Childhood
What this study did
NCT05032183 · M.D. Anderson Cancer Center
2022-02-17 – 2024-07-31 · Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Refractory Lymphoblastic Lymphoma, Refractory T Acute Lymphoblastic Leukemia
What this study did
NCT04752163 · M.D. Anderson Cancer Center
2021-03-25 – 2023-11-08 · Hematopoietic and Lymphoid Cell Neoplasm, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome
What this study did
NCT05320380 · Children's Oncology Group
2023-08-01 – 2023-09-01 · Recurrent Acute Myeloid Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Refractory B Acute Lymphoblastic Leukemia, Refractory Mixed Phenotype Acute Leukemia, Refractory T Acute Lymphoblastic Leukemia
What this study did
NCT00981799 · Therapeutic Advances in Childhood Leukemia Consortium
2010-06 – 2016-07-18 · Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma
What this study did
NCT01483690 · Therapeutic Advances in Childhood Leukemia Consortium
2011-12 – 2015-07-31 · Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia
What this study did
NCT00061945 · National Cancer Institute (NCI)
2003-06 – 2012-10 · Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
What this study did
NCT00372619 · Children's Oncology Group
2007-03 – 2012-08 · Leukemia
What this study did
NCT00098839 · Children's Oncology Group
2005-02 – 2011-04 · Recurrent Childhood Acute Lymphoblastic Leukemia
What this study did
NCT00440726 · Therapeutic Advances in Childhood Leukemia Consortium
2006-08-04 – 2011-02-26 · Acute Lymphoblastic Leukemia
What this study did
NCT00439296 · Therapeutic Advances in Childhood Leukemia Consortium
2006-05-22 – 2009-09-23 · Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia, Refractory Pediatric ALL
What this study did
Rheumatoid Arthritis
NCT03028467 · GlaxoSmithKline
2017-01-24 – 2017-12-20 · Arthritis, Rheumatoid
What this study did
NCT02202395 · Shanghai Pharmaceuticals Holding Co., Ltd
2014-06 – 2016-12-28 · Rheumatoid Arthritis
What this study did
NCT01737944 · Antares Pharma Inc.
2011-01 – 2011-06 · Rheumatoid Arthritis
What this study did
NCT01009242 · UCB Pharma
2009-10 – 2010-09 · Arthritis, Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT04961801 · Shin Mineishi
2022-03 – 2030-01 · Lymphoma, Leukemia
What this study did
NCT06554561 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2024-08-31 – 2029-08-31 · PCNSL
What this study did
NCT04396223 · Hospices Civils de Lyon
2020-02-12 – 2028-10-12 · Gestational Trophoblastic Neoplasias (GTN)
What this study did
NCT07559097 · Henan Cancer Hospital
2025-09-08 – 2027-12-31 · Leptomeningeal Metastasis From Lung Cancer
What this study did
NCT05698147 · Tong Chen, MD
2023-08-03 – 2026-12-31 · Central Nervous System Lymphoma
What this study did
NCT03842696 · University of Michigan Rogel Cancer Center
2020-02-04 – 2026-04-01 · Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase, Chronic Myelogenous Leukemia, Accelerated Phase, Chronic Myelogenous Leukemia, Blastic Phase, Myelodysplastic Syndromes, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Non Hodgkin Lymphoma, Graft Vs Host Disease, Graft-versus-host-disease
What this study did
NCT02315326 · Memorial Sloan Kettering Cancer Center
2014-12-08 – 2026-01-28 · Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL), Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)
What this study did
NCT04622956 · University of Sao Paulo General Hospital
2020-10-07 – 2025-12 · Graft Vs Host Disease, Hematopoietic Neoplasm
What this study did
NCT06289205 · University of Health Sciences Lahore
2024-03 – 2025-05 · Proliferative Vitreoretinopathy
What this study did
NCT06951282 · Ain Shams University
2024-05-02 – 2024-12-31 · Methotrexate Spermatotoxicity
What this study did
NCT05918718 · Tehran University of Medical Sciences
2023-01-20 – 2024-12-20 · Ectopic Pregnancy
What this study did
NCT04120350 · Peking Union Medical College Hospital
2019-08-16 – 2024-08 · Primary Central Nervous System Lymphoma
What this study did
NCT02481310 · Northwestern University
2015-10-28 – 2024-07 · Adult Burkitt Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, MYC Gene Mutation, Plasmablastic Lymphoma
What this study did
NCT03277924 · Grupo Espanol de Investigacion en Sarcomas
2017-05-31 – 2024-06-30 · Soft Tissue Sarcoma, Bone Sarcoma
What this study did
NCT01664910 · M.D. Anderson Cancer Center
2012-10-29 – 2023-06-28 · Hematopoietic and Lymphoid Cell Neoplasm
What this study did
NCT00293475 · OHSU Knight Cancer Institute
2005-10-14 – 2023-01-31 · Central Nervous System Lymphoma
What this study did
NCT02724904 · Massachusetts General Hospital
2017-05 – 2021-12 · Lymphoma
What this study did
NCT04610567 · University of Sao Paulo General Hospital
2020-10-27 – 2021-07-15 · Coronavirus, Inflammation, Covid19
What this study did
NCT04352465 · Azidus Brasil
2020-05-01 – 2020-11-30 · COVID-19
What this study did
NCT00477412 · M.D. Anderson Cancer Center
2007-04-03 – 2020-10-28 · Mantle Cell Lymphoma
What this study did
NCT02983942 · Beijing Tiantan Hospital
2017-01 – 2019-12 · Primary Central Nervous System Lymphoma
What this study did
NCT02328755 · University of Michigan Rogel Cancer Center
2015-01 – 2019-03-25 · Acute Myeloid Leukemia
What this study did
NCT01629511 · M.D. Anderson Cancer Center
2012-11-21 – 2018-04-25 · Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Richter Syndrome
What this study did
NCT03230708 · Hui ting Xu,MD
2017-05-01 – 2018-02-01 · Malignant Ascites
What this study did
NCT01379209 · Regimmune Corporation
2011-09 – 2017-04 · Graft Versus Host Disease
What this study did
NCT01875237 · M.D. Anderson Cancer Center
2013-12-27 – 2017-03-07 · Leukemia, Myeloma, Myeloproliferative Diseases
What this study did
NCT00068250 · Radiation Therapy Oncology Group
2003-07 – 2016-12 · Brain and Central Nervous System Tumors, Lymphoma
What this study did
Phase 1 (134)
Acute Lymphoblastic Leukemia
NCT05292664 · Andrew E. Place, MD
2023-03-29 – 2030-07-02 · Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary, Myelodysplastic Syndromes, Previously Treated, Treatment-Related Acute Myeloid Leukemia, Therapy-Related Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Lymphoblastic Lymphoma, in Relapse, Lymphoblastic Lymphoma, Refractory, Acute Leukemia of Ambiguous Lineage in Relapse, Acute Leukemia of Ambiguous Lineage
What this study did
NCT07498465 · Children's Oncology Group
2026-09-10 – 2028-11-12 · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia, Childhood Mixed Phenotype Acute Leukemia, Mixed Phenotype Acute Leukemia
What this study did
NCT07914166 · City of Hope Medical Center
2027-10-13 – 2028-10-13 · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
What this study did
NCT04872790 · OHSU Knight Cancer Institute
2022-09-02 – 2027-12-02 · B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Mixed Phenotype Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
What this study did
NCT03571321 · University of Chicago
2019-05-28 – 2027-09-05 · Acute Lymphoblastic Leukemia, ALL, Childhood, ALL
What this study did
NCT05157971 · City of Hope Medical Center
2022-03-17 – 2027-04-12 · B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia
What this study did
NCT03962465 · University of Virginia
2022-07-22 – 2026-07 · B-cell Acute Lymphoblastic Leukemia
What this study did
NCT02303821 · Amgen
2015-02-16 – 2024-06-28 · Acute Lymphoblastic Leukemia (ALL)
What this study did
NCT03792256 · Children's Oncology Group
2019-04-11 – 2023-09-30 · Leukemia, Lymphocytic, Lymphoblastic Lymphoma, T-cell Lymphoma, T-cell Leukemia, Recurrent Disease, Acute Leukemia
What this study did
NCT03964259 · Virginia Commonwealth University
2019-10-02 – 2022-12-28 · Lymphoma, Acute Lymphoblastic Leukemia, Pediatric Cancer, Pediatric ALL, Pediatric Lymphoma
What this study did
NCT03349281 · Julio Barredo, MD
2019-03-25 – 2022-10-12 · Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia
What this study did
NCT02122081 · Sumithira Vasu
2015-07-27 – 2022-09-06 · Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia
What this study did
NCT00866307 · Children's Oncology Group
2009-02-23 – 2021-03-31 · Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia
What this study did
NCT01614197 · Therapeutic Advances in Childhood Leukemia Consortium
2015-07-03 – 2020-09-04 · Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma, Peripheral T-cell Lymphoma
What this study did
NCT02228772 · Massachusetts General Hospital
2014-12 – 2019-11 · Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, B-cell Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia
What this study did
NCT02779283 · OHSU Knight Cancer Institute
2016-01-13 – 2018-09-20 · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
What this study did
NCT01187810 · South Plains Oncology Consortium
2010-08 – 2018-04 · Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
What this study did
NCT02293109 · Mehrdad Abedi, MD
2015-12-17 – 2018-01-11 · Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia
What this study did
NCT02212561 · St. Jude Children's Research Hospital
2014-08 – 2015-12 · Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS), Mixed Phenotype Acute Leukemia (MPAL)
What this study did
NCT01403415 · National Cancer Institute (NCI)
2011-09 – 2015-05 · Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma
What this study did
NCT01186328 · Therapeutic Advances in Childhood Leukemia Consortium
2010-08-24 – 2012-01-10 · Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, T Cell, Leukemia, Lymphoblastic, Acute
What this study did
NCT00928200 · Therapeutic Advances in Childhood Leukemia Consortium
2009-04-13 – 2010-06-04 · Relapsed Acute Lymphoblastic Leukemia, Allergy to PEG e.Coli Asparaginase, Allergy to Native e.Coli Asparaginase
What this study did
NCT00003217 · Children's Oncology Group
1998-03 – 2006-09 · Leukemia, Lymphoma
What this study did
Rheumatoid Arthritis
NCT05533372 · ILAb Co., Ltd.
2022-10-10 – 2025-10-15 · Healthy, Rheumatoid Arthritis
What this study did
NCT05508815 · Beijing University of Chinese Medicine
2023-02-09 – 2024-12-31 · Arthritis, Rheumatoid
What this study did
NCT05380934 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2022-05-29 – 2023-05-20 · Rheumatoid Arthritis
What this study did
NCT03131973 · Bristol-Myers Squibb
2017-05-13 – 2017-11-10 · Rheumatoid Arthritis
What this study did
NCT02698657 · Astellas Pharma Global Development, Inc.
2016-02-23 – 2017-09-07 · Rheumatoid Arthritis (RA)
What this study did
NCT02076659 · Philogen S.p.A.
2011-09 – 2017-04-13 · Rheumatoid Arthritis
What this study did
NCT02480946 · Modern Biosciences Ltd
2015-07 – 2017-03 · Arthritis, Rheumatoid
What this study did
NCT02940561 · Amneal Pharmaceuticals, LLC
2016-08 – 2016-10 · Psoriasis, Rheumatoid Arthritis
What this study did
NCT02867306 · Astellas Pharma Global Development, Inc.
2016-07-25 – 2016-08-30 · Rheumatoid Arthritis
What this study did
NCT02456844 · Bristol-Myers Squibb
2015-05 – 2015-07 · Rheumatoid Arthritis
What this study did
NCT01873443 · Celltrion
2013-05 – 2014-10 · Rheumatoid Arthritis
What this study did
NCT01749787 · Protalex, Inc.
2012-11 – 2014-08 · Arthritis, Rheumatoid
What this study did
NCT02171143 · Astellas Pharma Global Development, Inc.
2012-04 – 2014-04 · Rheumatoid Arthritis, Pharmacokinetics of ASP2409
What this study did
NCT01390441 · Merck Sharp & Dohme LLC
2011-07 – 2014-04 · Rheumatoid Arthritis
What this study did
NCT01850680 · Sanofi
2013-04 – 2013-12 · Rheumatoid Arthritis
What this study did
NCT02052375 · Astellas Pharma Global Development, Inc.
2012-06 – 2013-12 · Rheumatoid Arthritis, Pharmacokinetics of ASP2408
What this study did
NCT01871961 · medac GmbH
2012-10 – 2013-05 · Rheumatoid Arthritis (RA)
What this study did
NCT01442545 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2011-08 – 2011-12 · Rheumatoid Arthritis
What this study did
NCT01450982 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2011-06 – 2011-10 · Rheumatoid Arthritis
What this study did
NCT01329991 · Plexxikon
2011-05 – 2011-10 · Rheumatoid Arthritis
What this study did
NCT00965653 · Hoffmann-La Roche
2009-08 – 2011-07 · Rheumatoid Arthritis
What this study did
NCT01754805 · Astellas Pharma Inc
2010-01-22 – 2010-03-25 · Rheumatoid Arthritis
What this study did
NCT00920608 · AstraZeneca
2009-05 – 2009-09 · Rheumatoid Arthritis
What this study did
NCT00717808 · Imperial College London
2008-09 – 2009-09 · Rheumatoid Arthritis
What this study did
NCT00847886 · Lexicon Pharmaceuticals
2009-02 – 2009-03 · Rheumatoid Arthritis
What this study did
NCT00365001 · Hoffmann-La Roche
est. completion 2008-04 · Rheumatoid Arthritis
What this study did
NCT00440492 · Wyeth is now a wholly owned subsidiary of Pfizer
2006-12 – 2007-11 · Arthritis, Rheumatoid
What this study did
Phase 4 (177)
Acute Lymphoblastic Leukemia
NCT06289673 · St. Jude Children's Research Hospital
2024-12-26 – 2039-05 · Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Mixed Phenotype Acute Leukemia
What this study did
NCT01366898 · PETHEMA Foundation
2007-06-30 – 2022-12 · Acute Lymphoblastic Leukemia
What this study did
NCT01358201 · PETHEMA Foundation
2010-05 – 2022-12 · Acute Lymphoblastic Leukemia
What this study did
NCT00846703 · Sun Yat-sen University
2008-07 – 2018-12 · Acute Lymphoblastic Leukemia
What this study did
NCT02894645 · National University Hospital, Singapore
2008-10 – 2018-10 · Acute Lymphoblastic Leukemia (ALL)
What this study did
NCT02690922 · Tongji Hospital
2016-03 – 2017-05 · ph+ Acute Lymphoblastic Leukemia
What this study did
NCT00526175 · PETHEMA Foundation
2001-06 – 2015-12 · Acute Lymphoblastic Leukemia
What this study did
NCT00526409 · PETHEMA Foundation
2005-06 – 2014-10 · Acute Lymphoblastic Leukemia
What this study did
NCT00198978 · Goethe University
2003-01 – 2014-06 · Adult Acute Lymphocytic Leukemia
What this study did
NCT00198991 · Goethe University
2003-04 – 2013-06-30 · Adult Acute Lymphocytic Leukemia
What this study did
NCT01358253 · Ruijin Hospital
2010-12 – 2012-12 · Acute Lymphoblastic Leukemia
What this study did
NCT00853008 · PETHEMA Foundation
2003-01 – 2012-12 · Acute Lymphoblastic Leukemia
What this study did
NCT00199004 · Johann Wolfgang Goethe University Hospital
2004-04 – 2009-03 · Adult Acute Lymphocytic Leukemia
What this study did
NCT00494897 · PETHEMA Foundation
1996-06 – 2007-12 · Acute Lymphoblastic Leukemia
What this study did
NCT00199056 · Goethe University
1999-10 – 2005-12 · Adult Acute Lymphocytic Leukemia
What this study did
NCT00199095 · Goethe University
1997-02 – 2003-06 · Adult Acute Lymphocytic Leukemia
What this study did
NCT00199069 · Goethe University
1993-04 – 2001-05 · Adult Acute Lymphocytic Leukemia
What this study did
Rheumatoid Arthritis
NCT05879419 · University of Sao Paulo General Hospital
2023-05-23 – 2032-06-30 · Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis, Systemic Lupus Erythematosus, Sjogren's Syndrome, Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Vasculitis, Systemic, Juvenile Idiopathic Arthritis, Dermatomyositis, Juvenile, Behçet Disease
What this study did
NCT07802678 · Sint Maartenskliniek
2026-07-14 – 2029-05-01 · Rheumatoid Arthritis (RA)
What this study did
NCT06913907 · Keio University
2025-04-10 – 2027-12-31 · Rheumatoid Arthritis (RA)
What this study did
NCT06649136 · Medical University of Vienna
2024-08-12 – 2027-06-07 · Rheumatoid Arthritis
What this study did
NCT07636057 · Sheikh Zayed Federal Postgraduate Medical Institute
2026-07-05 – 2027-05-10 · Rheumatoid Arthritis (RA)
What this study did
NCT05626348 · Qilu Hospital of Shandong University
2021-12-22 – 2026-12-31 · Arthritis, Rheumatoid
What this study did
NCT05353829 · Region Västerbotten
2022-04-28 – 2026-12-31 · Rheumatoid Arthritis
What this study did
NCT05393050 · Quan Jiang
2022-07 – 2024-06 · Rheumatoid Arthritis
What this study did
NCT03254589 · Flinders University
2017-10-01 – 2023-12-31 · Rheumatoid Arthritis, Stiffness, Aortic, Endothelial Dysfunction, Cardiovascular Risk Factor
What this study did
NCT03855007 · Qilu Hospital of Shandong University
2016-01-01 – 2023-10-31 · Arthritis, Rheumatoid
What this study did
NCT03813771 · University of Leeds
2019-03 – 2023-02 · Rheumatoid Arthritis
What this study did
NCT03505008 · Keio University
2018-04-18 – 2021-05-11 · Rheumatoid Arthritis
What this study did
NCT02374021 · Brigham and Women's Hospital
2016-07 – 2021-05 · Arthritis, Rheumatoid
What this study did
NCT04464642 · Dr. Mohammad Mamun Khan
2019-07-10 – 2020-09 · Rheumatoid Arthritis
What this study did
NCT04066803 · Sun Yat-sen University
2018-08-01 – 2020-07-30 · Rheumatoid Arthritis
What this study did
NCT03445871 · Centre Hospitalier Universitaire de Saint Etienne
2018-07-02 – 2020-05-28 · Rheumatoid Arthritis
What this study did
NCT02878161 · Fen Li
2016-01 – 2019-12 · Rheumatoid Arthritis
What this study did
NCT03449758 · Sanofi
2018-03-05 – 2019-07-31 · Rheumatoid Arthritis
What this study did
NCT02433184 · University of Leeds
2011-07 – 2019-07 · Rheumatoid Arthritis
What this study did
NCT02874092 · NYU Langone Health
2016-11-15 – 2019-06-19 · Rheumatoid Arthritis
What this study did
NCT02557100 · Bristol-Myers Squibb
2015-11-19 – 2019-03-28 · Rheumatoid Arthritis
What this study did
NCT02831855 · Pfizer
2016-09-01 – 2018-12-17 · Rheumatoid Arthritis
What this study did
NCT04177173 · King Edward Medical University
2017-09-01 – 2018-12-14 · Arthritis, Rheumatoid
What this study did
NCT02451748 · University of Illinois at Chicago
2015-08 – 2017-12 · Rheumatoid Arthritis
What this study did
NCT02644499 · Jawaharlal Institute of Postgraduate Medical Education & Research
2015-12-31 – 2017-09-15 · Rheumatoid Arthritis
What this study did
NCT02748785 · Seoul National University Hospital
2015-09 – 2016-08 · Arthritis, Rheumatoid
What this study did
NCT07094880 · Bangladesh Medical University
2015-06-01 – 2016-06-01 · Methotrexate Adverse Reaction, Advantage of Using Subcutaneous Route for Methotrexate
What this study did
NCT04157010 · University of Leeds
2013-05 – 2016-03-29 · Rheumatoid Arthritis
What this study did
NCT02275299 · Jiangsu Simcere Pharmaceutical Co., Ltd.
2013-09 – 2016-02 · Rheumatoid Arthritis
What this study did
NCT01162421 · AbbVie (prior sponsor, Abbott)
2010-09 – 2015-07 · Rheumatoid Arthritis
What this study did
NCT01927757 · Amgen
2013-05-06 – 2015-06-11 · Moderate to Severe Rheumatoid Arthritis
What this study did
Early phase / not applicable (108)
Acute Lymphoblastic Leukemia
NCT01085617 · University College, London
2010-12 – 2025-02-24 · Leukemia, Mucositis, Oral Complications
What this study did
NCT05026229 · First Affiliated Hospital Xi'an Jiaotong University
2021-09-06 – 2023-06-30 · Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult
What this study did
NCT01376427 · PETHEMA Foundation
2007-01 – 2022-12 · Acute Lymphoblastic Leukemia Ph Positive
What this study did
NCT01953770 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology
2008-02 – 2020-07 · Childhood Acute Lymphoblastic Leukemia
What this study did
NCT01156883 · Gruppo Italiano Malattie EMatologiche dell'Adulto
2010-04 – 2017-10-31 · Leukemia
What this study did
NCT00096135 · Children's Oncology Group
2004-11 – 2013-09 · Leukemia
What this study did
NCT00343369 · Universitätsklinikum Hamburg-Eppendorf
started 2003-01 · Leukemia
What this study did
NCT00016302 · National Cancer Institute (NCI)
2001-04 – 2007-07 · T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
What this study did
NCT00049569 · National Cancer Institute (NCI)
2003-01 – 2006-03 · L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Non-T, Non-B Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
What this study did
NCT01225874 · Children's Oncology Group
1999-12 – 2006-03 · Leukemia
What this study did
Rheumatoid Arthritis
NCT06574594 · Konkuk University Medical Center
2024-08-22 – 2025-12-31 · Rheumatoid Arthritis
What this study did
NCT04758689 · Cairo University
2020-11-20 – 2020-12-22 · Rheumatoid Arthritis
What this study did
NCT03107299 · Centre Hospitalier Universitaire, Amiens
2016-07-05 – 2019-04-05 · Methotrexate, Polyarthritis; Rheumatoid
What this study did
NCT02897011 · Seoul National University Hospital
2016-09 – 2017-08 · Rheumatoid Arthritis, Influenza, Methotrexate
What this study did
NCT00405275 · US Department of Veterans Affairs
2007-07 – 2012-05 · Rheumatoid Arthritis
What this study did
NCT00901550 · Chinese University of Hong Kong
2008-11 – 2011-10 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT06946407 · FengYan Jin
2022-12-02 – 2029-12-01 · Primary Central Nervous System Lymphoma (PCNSL), CNS Lymphoma Treatment
What this study did
NCT07764601 · WEI XU
2026-08 – 2029-08 · Primary Central Nervous System Lymphoma, Diffuse Large B-Cell Lymphoma
What this study did
NCT06832267 · Zhejiang Cancer Hospital
2025-02-14 – 2028-02-13 · Primary Central Nervous System Lymphoma
What this study did
NCT07406230 · Assistance Publique Hopitaux De Marseille
2026-04 – 2027-12 · Primary Central Nervous System Lymphoma
What this study did
NCT06302465 · Peking University People's Hospital
2024-05-01 – 2026-12-31 · Malignant Bone Tumor
What this study did
NCT06877455 · Assiut University
2026-05-01 – 2026-12-30 · Vitiligo
What this study did
NCT07581418 · Pak Emirates Military Hospital
2026-06-01 – 2026-12-01 · Chronic Plaque Psoriasis
What this study did
NCT07937007 · Kafrelsheikh University
2025-08-01 – 2026-12 · Plantar Warts
What this study did
NCT07327476 · University of Health Sciences Lahore
2026-07-15 – 2026-11-30 · Chemotherapy Induced Oral Mucositis
What this study did
NCT07086924 · South Valley University
2025-06-01 – 2026-06-10 · Psoriasis, Psoriatic Arthritis
What this study did
NCT06870500 · South Valley University
2025-03-05 – 2026-03-10 · Psoriatic Arthritis
What this study did
NCT07208890 · Pharos University in Alexandria
2025-11-10 – 2026-03-10 · Vitiligo - Evaluation of Methotrexate Iontophoresis and Topical Methotrexate Gel as Localized Treatment Approache
What this study did
NCT04562558 · xiang yang
2020-09-29 – 2025-12 · Gestational Trophoblastic Tumor, Gestational Trophoblastic Neoplasia, Stage I Gestational Trophoblastic Tumor, Stage II Gestational Trophoblastic Tumor, Stage III Gestational Trophoblastic Tumor, Invasive Mole, Choriocarcinoma
What this study did
NCT03775460 · London School of Hygiene and Tropical Medicine
2023-01-15 – 2025-10-01 · Erythema Nodosum Leprosum
What this study did
NCT06554470 · Tanta University
2024-08-15 – 2025-07-01 · Local, Systemic, Methotrexate, Uterine Ectopic Pregnancy
What this study did
NCT06712238 · Aswan University
2024-06-10 – 2025-06-10 · Psoriatic Conditions
What this study did
NCT07058337 · Benha University
2024-06-09 – 2025-06-09 · Retinal Detachment
What this study did
NCT06150794 · Assiut University
2023-12-01 – 2025-03-01 · Nail Psoriasis
What this study did
NCT03360760 · Peking University People's Hospital
2018-08-01 – 2025-02 · Osteosarcoma of Pelvis
What this study did
NCT04169828 · University of British Columbia
2019-08-02 – 2025-01-17 · Juvenile Idiopathic Arthritis
What this study did
NCT06426979 · Zagazig University
2023-01-01 – 2024-01-01 · Pregnancy Tubal
What this study did
NCT05889338 · Sohag University
2023-06 – 2024-01 · Psoriasi
What this study did
NCT03815448 · Zhujiang Hospital
2019-07-18 – 2023-12-01 · Knee Osteoarthritis, Effusion Synovial, Knee Pain
What this study did
NCT05875285 · Cairo University
2023-06-01 – 2023-10-01 · Hyperhidrosis, Iontophore
What this study did
NCT05300009 · Assiut University
2022-06-15 – 2023-08-15 · Warts
What this study did
NCT02845596 · Michael Pulsipher
2016-08 – 2023-07-19 · Severe Aplastic Anemia
What this study did
NCT05839561 · Jagiellonian University
2020-12-01 – 2023-06-30 · Tubal Pregnancy Unruptured
What this study did
NCT05408208 · Sohag University
2022-05-21 – 2023-05-21 · Localized Psoriasis
What this study did
NCT04360785 · Assistance Publique - Hôpitaux de Paris
2020-11-11 – 2023-02-27 · Spondyloarthritis
What this study did
NCT05485571 · Sohag University
2022-08-01 – 2023-02-01 · Alopecia Areata
What this study did
Used as active comparator (109)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (58)
Acute Lymphoblastic Leukemia
NCT04314219 · King Faisal Specialist Hospital & Research Center
2021-08-15 – 2026-12 · Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid Leukemia (AML) in Remission
What this study did
NCT02393859 · Amgen
2015-11-10 – 2022-11-21 · Leukemia, Acute Lymphoblastic
What this study did
Rheumatoid Arthritis
NCT02647762 · Can-Fite BioPharma
2017-10-30 – 2020-11-30 · Rheumatoid Arthritis
What this study did
NCT02504268 · Bristol-Myers Squibb
2015-09-03 – 2020-03-19 · Rheumatoid Arthritis
What this study did
NCT02886728 · Gilead Sciences
2016-08-08 – 2019-05-08 · Rheumatoid Arthritis
What this study did
NCT01007435 · Hoffmann-La Roche
2009-10-31 – 2014-01-28 · Rheumatoid Arthritis
What this study did
NCT00264550 · Centocor, Inc.
2005-12 – 2012-05 · Rheumatoid Arthritis
What this study did
NCT01870128 · All India Institute of Medical Sciences
2009-08 – 2011-06 · Rheumatoid Arthritis
What this study did
NCT00445770 · Pfizer
2006-07 – 2010-07 · Arthritis, Rheumatoid
What this study did
NCT00361335 · Centocor, Inc.
2006-09 – 2009-09 · Rheumatoid Arthritis
What this study did
NCT00521924 · Merck Sharp & Dohme LLC
2007-06 – 2008-04 · Rheumatoid Arthritis
What this study did
NCT00109408 · Hoffmann-La Roche
2005-07 – 2007-12 · Rheumatoid Arthritis
What this study did
NCT00144521 · Chugai Pharmaceutical
2004-02 – 2006-04 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT06682169 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2024-11-20 – 2030-12 · Graft-versus-host Disease
What this study did
NCT06965244 · Assistance Publique - Hôpitaux de Paris
2025-10-01 – 2029-04-01 · Cutaneous Lupus Erythematosus (CLE)
What this study did
NCT07689630 · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
2026-05-01 – 2028-05 · Graft Versus Host Disease, Hematologic Neoplasms
What this study did
NCT05751512 · Lepu Biopharma Co., Ltd.
2023-04-04 – 2027-12 · Squamous Cell Carcinoma of the Head and Neck
What this study did
NCT03892785 · Centre Hospitalier Universitaire Dijon
2020-01-27 – 2026-03-27 · Giant Cell Arteritis
What this study did
NCT02639650 · Weiguo Lv
2016-03-01 – 2026-03-01 · Gestational Trophoblastic Neoplasms
What this study did
NCT04798755 · Hospital San Carlos, Madrid
2022-01-12 – 2025-10-01 · Uveitis
What this study did
NCT06936215 · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2024-01-01 – 2025-05 · Diffuse Cutaneous Systemic Sclerosis
What this study did
NCT02688140 · Technische Universität Dresden
2016-06 – 2025-01-20 · Acute Promyelocytic Leukemia
What this study did
NCT02085655 · Huiqiang Huang
2013-04-25 – 2022-12-31 · Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
What this study did
NCT03112603 · Incyte Corporation
2017-06-29 – 2022-12-15 · Graft-versus-host Disease (GVHD)
What this study did
NCT03959241 · Medical College of Wisconsin
2019-06-25 – 2022-09-19 · Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia, Lymphoma
What this study did
NCT02252042 · Merck Sharp & Dohme LLC
2014-11-17 – 2022-08-15 · Head and Neck Squamous Cell Cancer
What this study did
NCT02631239 · Ruijin Hospital
2016-03-16 – 2022-07-17 · Extranodal NK/T-cell Lymphoma, Nasal Type
What this study did
NCT03219437 · AbbVie
2018-07-30 – 2021-11-26 · Psoriasis
What this study did
NCT01884623 · Gustave Roussy, Cancer Campus, Grand Paris
2013-11-06 – 2021-10-12 · Head Neck Cancer Squamous Cell Recurrent
What this study did
NCT02105636 · Bristol-Myers Squibb
2014-05-29 – 2021-09-10 · Squamous Cell Carcinoma of the Head and Neck
What this study did
NCT02345850 · National Heart, Lung, and Blood Institute (NHLBI)
2015-08 – 2020-10-05 · Acute Leukemia, Myelodysplasia
What this study did
NCT01535053 · GOG Foundation
2012-06-18 – 2020-07-17 · Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor, FIGO Stage III Gestational Trophoblastic Tumor, Hydatidiform Mole
What this study did
NCT00482833 · Gruppo Italiano Malattie EMatologiche dell'Adulto
2007-08 – 2019-10-17 · Leukemia
What this study did
NCT03736161 · Globe Pharmaceuticals Limited
2017-09-15 – 2019-09-28 · Psoriatic Arthritis
What this study did
NCT02347332 · Pierre Fabre Medicament
2014-04-25 – 2018-11-23 · Recurrent or Metastatic Head and Neck Carcinoma
What this study did
NCT01871649 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2013-08 – 2018-11 · Psoriatic Arthritis
What this study did
NCT01578499 · Millennium Pharmaceuticals, Inc.
2012-06-11 – 2018-07-06 · Primary Cutaneous Anaplastic Large Cell Lymphoma, Mycosis Fungoides, Cutaneous T-Cell Lymphoma
What this study did
NCT02376790 · Amgen
2015-03-03 – 2018-07-06 · Psoriatic Arthritis
What this study did
NCT02634801 · Eli Lilly and Company
2016-01-20 – 2017-11-14 · Plaque Psoriasis
What this study did
NCT01345682 · Boehringer Ingelheim
2012-01-05 – 2016-12-06 · Head and Neck Neoplasms, Carcinoma, Squamous Cell
What this study did
NCT01749111 · Hospital Israelita Albert Einstein
2012-12 – 2016-08 · Acute Myelogenous Leukemia, Acute Lymphoid Leukemia, Myeloproliferative Disease, Myelodysplastic Syndrome, Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia
What this study did
NCT00406393 · Medical College of Wisconsin
2006-11 – 2015-10 · Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
What this study did
NCT01251614 · AbbVie (prior sponsor, Abbott)
2010-12 – 2015-02 · Plaque Psoriasis
What this study did
NCT01446211 · Nordic Pharma SAS
2011-11 – 2015-01 · Wegeners Granulomatosis
What this study did
NCT00331097 · National Cancer Institute, Naples
2003-07 – 2014-11 · Breast Cancer
What this study did
NCT00344253 · Heidelberg University
2006-03 – 2012-01 · Uveitis, Intermediate, Macular Edema, Multiple Sclerosis
What this study did
NCT00296010 · ETOP IBCSG Partners Foundation
2005-08 – 2011-12 · Breast Cancer
What this study did
Phase 2/3 (6)
Rheumatoid Arthritis
NCT01410695 · AB Science
2011-07 – 2015-10 · Rheumatoid Arthritis (RA)
What this study did
NCT01613079 · Peking Union Medical College Hospital
2012-05 – 2013-06 · Arthritis, Rheumatoid
What this study did
Other / comorbidity
NCT02265770 · Centre Leon Berard
2015-06-02 – 2031-08 · Childhood Ependymoma
What this study did
NCT05684744 · Cairo University
2023-01-09 – 2023-05-14 · Psoriasis
What this study did
NCT01204437 · GBG Forschungs GmbH
2009-03 – 2014-01 · Breast Cancer
What this study did
Phase 2 (14)
Rheumatoid Arthritis
NCT01116141 · Chelsea Therapeutics
2010-09 – 2012-05 · Rheumatoid Arthritis
What this study did
NCT00658047 · Chelsea Therapeutics
2008-04 – 2009-06 · Arthritis, Rheumatoid
What this study did
Other / comorbidity
NCT03703271 · Women's Hospital School Of Medicine Zhejiang University
2019-03-01 – 2026-12-31 · Gestational Trophoblastic Neoplasia
What this study did
NCT07361133 · National Cancer Institute, Egypt
2026-04 – 2026-09 · Squamous Cell Carcinoma, Advanced Head and Neck Cancer
What this study did
NCT07543640 · Eman Raafat Said
2026-04-01 – 2026-08 · Flexural Psoriasis (Also Known as Inverse or Intertriginous Psoriasis) and Genital Psoriasis
What this study did
NCT02299999 · UNICANCER
2014-04-07 – 2025-12 · Metastatic Breast Cancer
What this study did
NCT05263505 · Washington University School of Medicine
2022-02-21 – 2023-09-11 · Mucous Membrane Pemphigoid, Cicatrizing Conjunctivitis
What this study did
NCT03680092 · Dimitrios Tzachanis, MD PhD
2019-11-26 – 2023-06-15 · GVHD, Hematologic Neoplasms
What this study did
NCT03193931 · AIO-Studien-gGmbH
2018-02-02 – 2022-03-23 · Cancer of Head and Neck
What this study did
NCT01876082 · Institut Bergonié
2012-09-18 – 2019-09 · Progressive Desmoids Tumors
What this study did
NCT01528163 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
2012-02 – 2014-11 · Squamous Cell Carcinoma of the Head and Neck
What this study did
NCT00230035 · National Institute of Allergy and Infectious Diseases (NIAID)
started 2005-09 · Systemic Lupus Erythematosus
What this study did
NCT00775632 · University Health Network, Toronto
2008-10 – 2010-09 · Graft Versus Host Disease, Bone Marrow Transplantation
What this study did
NCT02701517 · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
2003-09 – 2009-11 · Unrecognized Condition: Mature B or T-cell Neoplasm
What this study did
Phase 1/2 (1)
Other / comorbidity
NCT00241189 · University of California, Los Angeles
2002-08 – 2006-06 · Systemic Sclerosis
What this study did
Phase 1 (2)
Other / comorbidity
NCT04967950 · Peking Union Medical College Hospital
2021-07-15 – 2022-12-31 · Psoriatic Arthritis
What this study did
NCT03424629 · Tianjin Ever Union Biotechnology Co., Ltd.
2018-06-01 – 2019-12-31 · Moderate and Severe Plaque Psoriasis
What this study did
Phase 4 (23)
Rheumatoid Arthritis
NCT07643038 · Chinese SLE Treatment And Research Group
2026-09-20 – 2029-07-31 · Rheumatoid Arthritis Associated Interstitial Lung Disease
What this study did
NCT05827497 · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2023-04-01 – 2024-03-31 · Rheumatoid Arthritis
What this study did
NCT04311567 · Vastra Gotaland Region
2020-11-07 – 2024-03-26 · Rheumatoid Arthritis, Interstitial Lung Disease Due to Systemic Disease (Disorder), RA, ILD
What this study did
NCT02837978 · Qiang Shu
2015-01 – 2022-12-30 · Arthritis, Rheumatoid
What this study did
NCT03589833 · Peking Union Medical College Hospital
2019-05-14 – 2022-07-27 · Arthritis, Rheumatoid
What this study did
NCT03737708 · Astellas Pharma Korea, Inc.
2019-02-13 – 2020-06-16 · Rheumatoid Arthritis (RA)
What this study did
NCT02764515 · Chinese SLE Treatment And Research Group
2015-09 – 2017-11 · Rheumatoid Arthritis
What this study did
NCT01548001 · Jiangsu Simcere Pharmaceutical Co., Ltd.
2012-05 – 2017-01 · Rheumatoid Arthritis
What this study did
NCT01303874 · University of Leeds
2006-09 – 2010-11-05 · Rheumatoid Arthritis, Inflammatory Arthritis
What this study did
Other / comorbidity
NCT04537689 · Singapore General Hospital
2020-12-10 – 2027-12-31 · Plaque Psoriasis
What this study did
NCT04239859 · Singapore General Hospital
2024-01 – 2027-12 · Plaque Psoriasis
What this study did
NCT06354439 · Hospital de Clinicas de Porto Alegre
2024-03-27 – 2026-12-31 · Ectopic Pregnancy
What this study did
NCT07406204 · Hayat Abad Medical Complex, Peshawar
2026-02-15 – 2026-08-15 · Alopecia Areata, Alopecia Totalis (AT), Alopecia Universalis
What this study did
NCT05102448 · Shanghai Zhongshan Hospital
2021-11-01 – 2025-12-31 · Takayasu Arteritis
What this study did
NCT06260904 · All India Institute of Medical Sciences, Bhubaneswar
2024-01-26 – 2025-10-30 · Oral Lichen Planus
What this study did
NCT07472166 · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2024-12-21 – 2025-08-30 · Scleroderma, Systemic
What this study did
NCT05984381 · All India Institute of Medical Sciences, Bhubaneswar
2023-08-01 – 2025-04-01 · Bullous Pemphigoid
What this study did
NCT04944524 · Shanghai Zhongshan Hospital
2021-07-01 – 2024-07-01 · Granulomatosis With Polyangiitis
What this study did
NCT04299971 · Shanghai Zhongshan Hospital
2020-03-01 – 2023-12-31 · Takayasu Arteritis, Methotrexate, Inhibition, Treatment
What this study did
NCT05015335 · Peking Union Medical College Hospital
2021-08-19 – 2023-07 · Uveitis, Anterior, Adalimumab
What this study did
NCT04469829 · Universita di Verona
2020-08-01 – 2022-12-31 · Psoriasis, Metabolic Syndrome
What this study did
NCT03797872 · University of Oxford
2019-04-17 – 2020-07-16 · Psoriatic Arthritis
What this study did
NCT01059773 · Janssen-Cilag International NV
2009-10 – 2011-08 · Psoriasis
What this study did
Early phase / not applicable (5)
Rheumatoid Arthritis
NCT06301373 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
2024-09-01 – 2029-12-31 · Rheumatoid Arthritis
What this study did
NCT07089381 · Ain Shams University
2025-08-01 – 2026-06-01 · Rheumatic Arthritis, Rheumatoid Arthritis (RA) Prevention, Inflamation, Antioxidant, Anti Oxidative Stress, Anti Aging, C Reactive Protein, Methotrexate, Quality of Life Outcomes
What this study did
NCT01617590 · Shanxi Medical University
2012-05 – 2014-05 · Rheumatoid Arthritis
What this study did
NCT01245452 · Patrick Durez
2010-05 – 2013-06 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT06088147 · Al-Azhar University
2023-12 – 2024-06 · Alopecia Areata
What this study did
Appears in other studies (99)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 3 (30)
Acute Lymphoblastic Leukemia
NCT00549848 · St. Jude Children's Research Hospital
2007-10-29 – 2022-03-26 · Acute Lymphoblastic Leukemia
What this study did
NCT04095858 · Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
2021-01-05 – 2021-11-05 · Hematopoietic Stem Cell Transplantation, Acute Graft Versus Host Disease, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes
What this study did
NCT00187005 · St. Jude Children's Research Hospital
1998-07 – 2002-07 · Acute Lymphoblastic Leukemia
What this study did
Rheumatoid Arthritis
NCT03016013 · RemeGen Co., Ltd.
2017-03-29 – 2022-12-29 · Moderate and Severe RheumatoId Arthritis
What this study did
NCT03522415 · Shanghai Henlius Biotech
2018-05-28 – 2020-09-11 · Moderately to Severely Active Rheumatoid Arthritis
What this study did
NCT01709760 · Mycenax Biotech Inc.
2012-11 – 2019-12 · Rheumatoid Arthritis
What this study did
NCT02889796 · Gilead Sciences
2016-08-30 – 2019-06-20 · Rheumatoid Arthritis
What this study did
NCT00476996 · Genentech, Inc.
2007-05-15 – 2018-05-14 · Rheumatoid Arthritis
What this study did
NCT02151851 · UCB Pharma SA, Belgium
2014-07 – 2016-06 · Rheumatoid Arthritis
What this study did
NCT01710358 · Eli Lilly and Company
2012-10 – 2015-09 · Rheumatoid Arthritis
What this study did
NCT00406419 · Genentech, Inc.
2006-12-27 – 2015-04-22 · Rheumatoid Arthritis
What this study did
NCT01451203 · Astellas Pharma Inc
2011-10-11 – 2014-10-20 · Rheumatoid Arthritis
What this study did
NCT00299104 · Genentech, Inc.
2006-01 – 2013-07 · Rheumatoid Arthritis
What this study did
NCT00578305 · Hoffmann-La Roche
2007-11 – 2013-05 · Rheumatoid Arthritis
What this study did
NCT00409838 · Bristol-Myers Squibb
2007-04 – 2011-12 · Rheumatoid Arthritis
What this study did
NCT00993317 · Korea Otsuka Pharmaceutical Co., Ltd.
2009-10 – 2011-08 · Rheumatoid Arthritis
What this study did
NCT00673920 · Genentech, Inc.
2008-04-24 – 2009-10-26 · Rheumatoid Arthritis
What this study did
NCT00048568 · Bristol-Myers Squibb
2002-12 – 2009-10 · Rheumatoid Arthritis
What this study did
NCT00266227 · Genentech, Inc.
2006-01 – 2007-10 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT04108468 · The Leeds Teaching Hospitals NHS Trust
2015-10-27 – 2023-07 · Psoriatic Arthritis
What this study did
NCT02065713 · Instituto de Medicina Molecular João Lobo Antunes
2014-08 – 2017-06 · Psoriatic Arthritis
What this study did
NCT00642460 · Hoffmann-La Roche
2008-05 – 2014-08 · Juvenile Idiopathic Arthritis
What this study did
NCT01230827 · Janssen Research & Development, LLC
2010-12 – 2014-05 · Juvenile Idiopathic Arthritis
What this study did
NCT00136084 · St. Jude Children's Research Hospital
2002-08 – 2012-06 · Leukemia, Myelocytic, Acute
What this study did
NCT00539838 · Genentech, Inc.
2007-12-19 – 2011-07-12 · Systemic Lupus Erythematosus
What this study did
NCT00544232 · GBG Forschungs GmbH
2002-08 – 2006-09 · Breast Cancer
What this study did
Phase 2/3 (3)
Rheumatoid Arthritis
NCT04170504 · Guang'anmen Hospital of China Academy of Chinese Medical Sciences
2019-11-14 – 2022-06-28 · Rheumatoid Arthritis
What this study did
NCT02885597 · Cui xuejun
2018-07 – 2020-12 · Juanbi Pill, Rheumatoid Arthritis
What this study did
NCT01061736 · Sanofi
2010-03 – 2013-10 · Rheumatoid Arthritis
What this study did
Phase 2 (49)
Acute Lymphoblastic Leukemia
NCT03779854 · Fred Hutchinson Cancer Center
2019-08-29 – 2027-08-31 · Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blasts Under 25 Percent of Bone Marrow Nucleated Cells, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome/Acute Myeloid Leukemia, Burkitt Leukemia, Chronic Monocytic Leukemia, Lymphoblastic Lymphoma, Mast Cell Leukemia, Myeloproliferative Neoplasm
What this study did
NCT00195871 · Centre Henri Becquerel
2004-02 – 2015-12 · Lymphoblastic Lymphoma
What this study did
NCT00184041 · University of Southern California
2004-07 – 2012-12 · Acute Lymphoblastic Leukemia
What this study did
NCT00489203 · Fred Hutchinson Cancer Center
2007-04 – 2010-11 · Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Atypical Chronic Myeloid Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Extramedullary Plasmacytoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Graft Versus Host Disease, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Meningeal Chronic Myelogenous Leukemia, Myelodysplastic/Myeloproliferative Disease, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma
What this study did
NCT00187161 · St. Jude Children's Research Hospital
1994-11 – 2007-01 · Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Mature B-Cell
What this study did
Rheumatoid Arthritis
NCT07176390 · Merck Sharp & Dohme LLC
2025-10-08 – 2029-03-01 · Arthritis, Rheumatoid
What this study did
NCT07895524 · Merck Sharp & Dohme LLC
2026-11-23 – 2028-11-28 · Rheumatoid Arthritis
What this study did
NCT07864688 · Al-Azhar University
2026-12 – 2027-12 · Rheumatoid Arthritis (RA)
What this study did
NCT06800157 · Shanghai Longwood Biopharmaceuticals Co., Ltd.
2023-02-27 – 2024-08-30 · Arthritis, Rheumatoid
What this study did
NCT05279417 · Aclaris Therapeutics, Inc.
2022-02-01 – 2023-10-11 · Rheumatoid Arthritis
What this study did
NCT02270632 · Philogen S.p.A.
2014-10-01 – 2023-06-08 · Rheumatoid Arthritis
What this study did
NCT04038970 · Jiangsu Alphamab Biopharmaceuticals Co., Ltd
2019-11-08 – 2022-07-28 · Rheumatoid Arthritis
What this study did
NCT03813199 · Abivax S.A.
2019-07-04 – 2021-04-27 · Rheumatoid Arthritis
What this study did
NCT04247815 · Aclaris Therapeutics, Inc.
2020-03-16 – 2021-02-04 · Rheumatoid Arthritis
What this study did
NCT03257852 · Astellas Pharma Inc
2017-09-29 – 2018-10-16 · Rheumatoid Arthritis (RA)
What this study did
NCT02833350 · Genentech, Inc.
2016-09-09 – 2018-07-02 · Rheumatoid Arthritis
What this study did
NCT02638948 · Bristol-Myers Squibb
2016-02-16 – 2018-05-03 · Rheumatoid Arthritis
What this study did
NCT02504671 · GlaxoSmithKline
2015-07-23 – 2017-12-29 · Arthritis, Rheumatoid
What this study did
NCT02799472 · GlaxoSmithKline
2016-06-15 – 2017-10-30 · Arthritis, Rheumatoid
What this study did
NCT02884635 · Astellas Pharma Inc
2016-09-16 – 2017-10-25 · Rheumatoid Arthritis
What this study did
NCT02885181 · Gilead Sciences
2016-09-21 – 2017-09-20 · Rheumatoid Arthritis
What this study did
NCT02862574 · Gilead Sciences
2016-12-15 – 2017-08-07 · Rheumatoid Arthritis
What this study did
NCT02379091 · Takeda
2014-12-17 – 2016-12-05 · Rheumatoid Arthritis
What this study did
NCT02309359 · Ablynx, a Sanofi company
2015-01 – 2016-08 · Rheumatoid Arthritis
What this study did
NCT04192617 · SinoMab BioScience Ltd
2014-12-31 – 2016-02-03 · Rheumatoid Arthritis
What this study did
NCT02029599 · Maoxiang Group Jilin Pharmaceutical Co., Ltd.
2014-03 – 2015-08 · Rheumatoid Arthritis
What this study did
NCT01909427 · Janssen Research & Development, LLC
2013-06 – 2015-05 · Rheumatoid Arthritis
What this study did
NCT00779220 · Chugai Pharmaceutical
2008-10 – 2015-03 · Rheumatoid Arthritis
What this study did
NCT01679951 · Janssen Research & Development, LLC
2012-10-31 – 2014-07-03 · Rheumatoid Arthritis
What this study did
NCT01469013 · Eli Lilly and Company
2011-11 – 2013-12 · Arthritis, Rheumatoid
What this study did
NCT01569152 · Merck Sharp & Dohme LLC
2012-05-22 – 2013-10-03 · Rheumatoid Arthritis (RA)
What this study did
NCT01010581 · 4SC AG
2009-11 – 2011-07 · Rheumatoid Arthritis
What this study did
NCT00976599 · Pfizer
2009-11 – 2011-07 · Rheumatoid Arthritis
What this study did
NCT00074438 · Genentech, Inc.
2003-06 – 2011-07 · Rheumatoid Arthritis
What this study did
NCT00950989 · Amgen
2009-12-30 – 2011-02-11 · Rheumatoid Arthritis
What this study did
NCT00207714 · Centocor, Inc.
2003-11 – 2006-02 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT00945724 · International Extranodal Lymphoma Study Group (IELSG)
2009-09-27 – 2023-09-26 · Large B-cell Diffuse Lymphoma of Testis
What this study did
NCT01399372 · Radiation Therapy Oncology Group
2011-09 – 2022-05-20 · Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Lymphoma, Neurotoxicity, Radiation Toxicity
What this study did
NCT02663622 · Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
2016-09-19 – 2021-05-18 · Graft Versus Host Disease, Hematopoietic Stem Cell Transplantation, Leukemia
What this study did
NCT03239600 · GlaxoSmithKline
2017-09-19 – 2017-10-12 · Autoimmune Diseases
What this study did
NCT04154852 · University of Leeds
2011-06 – 2017-01-16 · Oligoarthritis
What this study did
NCT01067989 · HaEmek Medical Center, Israel
2010-03 – 2014-04 · Chemotherapy, Breast Cancer, Metastatic
What this study did
NCT00189488 · Swedish Orphan Biovitrum
2005-12 – 2013-08 · Graft Versus Host Disease, Hematologic Malignancies
What this study did
NCT01227408 · University of Southern California
2009-02 – 2011-02 · Breast Cancer
What this study did
NCT00516152 · University of California, San Francisco
2002-11 – 2007-11 · Chronic Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplasia, Acute Lymphocytic Leukemia, Severe Aplastic Anemia, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease, Multiple Myeloma, Advanced Myeloproliferative Disease
What this study did
NCT00659412 · Astellas Pharma Inc
2003-09 – 2005-03 · Psoriatic Arthritis
What this study did
Phase 1/2 (3)
Rheumatoid Arthritis
NCT00959036 · Ablynx, a Sanofi company
2009-09 – 2011-01 · Active Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT02054442 · Radboud University Medical Center
2016-08 – 2022-12 · Squamous Cell Carcinoma of the Head and Neck
What this study did
NCT00299182 · M.D. Anderson Cancer Center
2006-03 – 2012-04 · Lymphoma
What this study did
Phase 1 (2)
Other / comorbidity
NCT02897700 · Shanghai Jiao Tong University School of Medicine
2013-01 – 2027-12 · Breast Cancer
What this study did
NCT07446400 · Otsuka Pharmaceutical Development & Commercialization, Inc.
2026-03-31 – 2026-11-07 · Healthy Volunteers
What this study did
Phase 4 (8)
Rheumatoid Arthritis
NCT03492658 · Leiden University Medical Center
2018-05-17 – 2022-04-06 · Rheumatoid Arthritis, Rheumatic Diseases
What this study did
NCT01758198 · Bristol-Myers Squibb
2013-04-11 – 2016-12-26 · Rheumatoid Arthritis
What this study did
NCT00716248 · Saitama Medical University
2007-01 – 2011-12 · Rheumatoid Arthritis
What this study did
NCT01308255 · University of Leeds
2006-09 – 2011-02 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT05518383 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology
2022-05-25 – 2027-05-16 · Non-hodgkin Lymphoma,B Cell, Burkitt Lymphoma, Primary Mediastinal Lymphoma, Primary CNS Lymphoma, Diffuse Large B-cell Lymphoma
What this study did
NCT04083066 · Mingzhi Zhang
2019-09-05 – 2024-04-01 · Primary Central Nervous System Lymphoma
What this study did
NCT04971239 · Assiut University
2021-10-01 – 2022-10-01 · Psoriasis, Methotrexate
What this study did
NCT00153530 · Charite University, Berlin, Germany
2000-05 – 2009-05 · Central Nervous System Lymphoma
What this study did
Early phase / not applicable (4)
Rheumatoid Arthritis
NCT01619176 · Chinese Academy of Sciences
2012-10 – 2014-12 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT05503875 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2023-01-01 – 2027-12-31 · Immunoclassification, Psoriasis
What this study did
NCT03058900 · Odense University Hospital
2017-05-16 – 2020-06-02 · Psoriatic Arthritis
What this study did
NCT00187070 · St. Jude Children's Research Hospital
1997-12 – 2001-07 · Lymphoma, Large Cell, Lymphoma, Non-Hodgkin
What this study did

Competitive landscape

This drug's own stage for Acute Lymphoblastic Leukemia: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Methotrexate: this drugApprovedSmall moleculeDihydrofolate reductase (DHFR), Folate Analog Metabolic Inhibitornot yet gradedNo reviewed efficacy summary in this indication
BlinatumomabApprovedMultispecific antibodyCD19 x CD3Weak signal
NCT03476239: Percentage of Participants With a Hematological Response of Complete Remission (CR) or Complete Remission With Partial Hematological Recovery (CRh*) During the First 2 Treatment Cycles With Blinatumomab (Within 2 cycles of treatment (12 weeks)): Blinatumomab — Interim Analysis: 45.6 percentage of participants (95% CI 35 to 56.4); Final Analysis: 48.3 percentage of participants (95% CI 39.1 to 57.6)
Obecabtagene Autoleucel (Aucatzyl)ApprovedCell therapyCD19not yet gradedNo reviewed efficacy summary in this indication
Ponatinib (ICLUSIG)ApprovedSmall moleculeBCR-ABL (including T315I)Partial signalFeatured results are non-efficacy only in this race
RevumenibApprovedSmall moleculeMeninWeak signalNo reviewed efficacy summary in this indication
ZiftomenibPhase 1/2Small moleculeMeninnot yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(147 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Methotrexate to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (22)
November 2026 (7)
Phase 2CNS LymphomaNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2026-11 · NCT06901999 · CT.gov ↗
What to watch
Phase 2Acute Myeloid Leukemia, Myelodysplastic SyndromesActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2026-11 · NCT03121014 · CT.gov ↗
What to watch
Phase 2Sickle Cell DiseaseActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2026-11 · NCT04018937 · CT.gov ↗
What to watch
Phase 3Moderate to Severe Atopic DermatitisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-11 · NCT06239311 · CT.gov ↗
What to watch
Early phase / not applicablePlantar WartsRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-11 · NCT07937007 · CT.gov ↗
What to watch
Phase 3Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2026-11-30 · NCT03020030 · CT.gov ↗
What to watch
Early phase / not applicableVitiligoNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2026-11-30 · NCT06877455 · CT.gov ↗
What to watch
December 2026 (15)
Phase 2GVHD,Acute, Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative DisordersRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12 · NCT06315309 · CT.gov ↗
What to watch
Phase 2Metastatic Breast Cancer, Leptomeningeal DiseaseRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12 · NCT02422641 · CT.gov ↗
What to watch
Phase 3Cardiac Sarcoidosis, SarcoidosisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12 · NCT03593759 · CT.gov ↗
What to watch
Phase 1/2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-01 · NCT06207123 · CT.gov ↗
What to watch
Phase 2Precursor Cell Lymphoblastic Leukemia-LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-01 · NCT06387121 · CT.gov ↗
What to watch
Early phase / not applicableChronic Plaque PsoriasisNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-01 · NCT07581418 · CT.gov ↗
What to watch
Phase 2Leptomeningeal Metastasis of Breast CancerRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-13 · NCT06543992 · CT.gov ↗
What to watch
Phase 1GoutRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-30 · NCT06298071 · CT.gov ↗
What to watch
Phase 1Lymphoma, Primary Central Nervous System LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-30 · NCT06475235 · CT.gov ↗
What to watch
Phase 2Diffuse Large B-cell LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-30 · NCT05257018 · CT.gov ↗
What to watch
Phase 1/2Leptomeningeal Metastasis From Lung CancerRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-31 · NCT07559097 · CT.gov ↗
What to watch
Phase 2Blastic Plasmacytoid Dendritic Cell NeoplasmRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-31 · NCT04216524 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-31 · NCT02981628 · CT.gov ↗
What to watch
Phase 3T-cell Lymphoblastic LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-31 · NCT05681260 · CT.gov ↗
What to watch
Phase 4Rheumatoid ArthritisActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2026-12-31 · NCT05353829 · CT.gov ↗
What to watch
2027 (51)
January 2027 (4)
Phase 1Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Leukemia of Ambiguous LineageRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-01 · NCT06177067 · CT.gov ↗
What to watch
Phase 2Vulvar Lichen SclerosusRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-01 · NCT07352917 · CT.gov ↗
What to watch
Phase 2Rheumatoid ArthritisNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-01-15 · NCT06590090 · CT.gov ↗
What to watch
Phase 2Caesarean Scar PregnancyNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-01-20 · NCT07288307 · CT.gov ↗
What to watch
February 2027 (4)
Phase 2Non-Hodgkin LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-02 · NCT05583071 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-02-01 · NCT05519579 · CT.gov ↗
What to watch
Early phase / not applicablePrimary Central Nervous System LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-02-13 · NCT06832267 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-02-28 · NCT03147612 · CT.gov ↗
What to watch
March 2027 (3)
Phase 2Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-03 · NCT04329325 · CT.gov ↗
What to watch
Phase 4Rheumatoid ArthritisNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-03-05 · NCT07636057 · CT.gov ↗
What to watch
Phase 2Mantle Cell LymphomaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-03-22 · NCT03710772 · CT.gov ↗
What to watch
April 2027 (5)
Early phase / not applicablePrimary Central Nervous System LymphomaNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-04 · NCT07406230 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-04-01 · NCT05303792 · CT.gov ↗
What to watch
Phase 1Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-04-12 · NCT05157971 · CT.gov ↗
What to watch
Phase 2Rheumatoid ArthritisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-04-15 · NCT07409103 · CT.gov ↗
What to watch
Phase 2Hematopoietic and Lymphatic System NeoplasmRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-04-30 · NCT06895473 · CT.gov ↗
What to watch
May 2027 (1)
Phase 2Rheumatoid ArthritisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-05-30 · NCT06998628 · CT.gov ↗
What to watch
June 2027 (5)
Phase 2Polycythemia Vera (PV), Essential Thrombocythemia (ET), Myelofibrosis (MF)RecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-06 · NCT06541249 · CT.gov ↗
What to watch
Phase 2Ectopic PregnancyNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-06 · NCT07624903 · CT.gov ↗
What to watch
Phase 3Mature B-cell Non-Hodgkin LymphomaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-06 · NCT03206671 · CT.gov ↗
What to watch
Phase 4Rheumatoid ArthritisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-06-07 · NCT06649136 · CT.gov ↗
What to watch
Phase 2Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell LymphomaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-06-30 · NCT02427620 · CT.gov ↗
What to watch
July 2027 (1)
Phase 2Relapsing PolychondritisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-07 · NCT06941376 · CT.gov ↗
What to watch
August 2027 (4)
Phase 2NeuroblastomaNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-08 · NCT05303727 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-08 · NCT01920737 · CT.gov ↗
What to watch
Phase 1Primary Diffuse Large B-Cell Lymphoma of the Central Nervous SystemActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-08-01 · NCT04609046 · CT.gov ↗
What to watch
Phase 3Investigate the Effect(s) of Methotrexate Treatment on Arthritis Disease SeverityActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-08-30 · NCT04483466 · CT.gov ↗
What to watch
September 2027 (4)
Early phase / not applicableLymphoma CnsRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-09-02 · NCT07191431 · CT.gov ↗
What to watch
Phase 2/3Renal Pelvis and Ureter Urothelial CarcinomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-09-30 · NCT04628767 · CT.gov ↗
What to watch
Phase 3Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-09-30 · NCT03914625 · CT.gov ↗
What to watch
Phase 4PhenylketonuriaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-09-30 · NCT07477691 · CT.gov ↗
What to watch
October 2027 (2)
Phase 2Primary Intraocular LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-10-30 · NCT06973811 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-10-31 · NCT01424982 · CT.gov ↗
What to watch
November 2027 (4)
Phase 1Central Nervous System LymphomaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-11 · NCT03684980 · CT.gov ↗
What to watch
Phase 3Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-11-01 · NCT03150693 · CT.gov ↗
What to watch
Phase 4Alopecia Areata(AA), Alopecia Areata (AA), Alopecia Totalis/Universalis, Alopecia Universalis (AU), Alopecia Totalis (AT) …RecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-11-01 · NCT07381556 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-11-30 · NCT03263572 · CT.gov ↗
What to watch
December 2027 (14)
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12 · NCT06390319 · CT.gov ↗
What to watch
Phase 2GoutRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12 · NCT07280156 · CT.gov ↗
What to watch
Phase 4Juvenile Idiopathic ArthritisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12 · NCT06653634 · CT.gov ↗
What to watch
Phase 2Hematologic Malignancies, Haploidentical Peripheral Blood Stem Cell Transplantation, Acute Graft-Versus-Host DiseaseNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-01 · NCT07926698 · CT.gov ↗
What to watch
Early phase / not applicablePrimary Central Nervous System Lymphoma (PCNSL), CNS Lymphoma TreatmentRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-01 · NCT06946407 · CT.gov ↗
What to watch
Phase 1Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-02 · NCT04872790 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-15 · NCT05660473 · CT.gov ↗
What to watch
Phase 1/2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-25 · NCT01371630 · CT.gov ↗
What to watch
Phase 4Autoimmune Rheumatic DiseasesRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-30 · NCT07242092 · CT.gov ↗
What to watch
Phase 1NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-31 · NCT03719105 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-31 · NCT05761171 · CT.gov ↗
What to watch
Phase 2LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-31 · NCT05645718 · CT.gov ↗
What to watch
Phase 4Rheumatoid ArthritisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-31 · NCT06913907 · CT.gov ↗
What to watch
Phase 4Psoriatic Arthritis (PsA)RecruitingStudy of the molecule, not a specific product
Est. primary completion 2027-12-31 · NCT07486843 · CT.gov ↗
What to watch
2028 (41)
January 2028 (4)
Phase 2Rheumatic DiseaseRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-01 · NCT07138898 · CT.gov ↗
What to watch
Phase 2Primary Central Nervous System Lymphoma (PCNSL), Non Hodgkin Lymphoma (NHL)Not yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-01-01 · NCT06646211 · CT.gov ↗
What to watch
Phase 2/3NPC, HNSCC, Recurrence, MetastasisNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-01-01 · NCT06719479 · CT.gov ↗
What to watch
Phase 2LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-01-09 · NCT07015242 · CT.gov ↗
What to watch
February 2028 (2)
Phase 2/3Erosive Hand OsteoarthritisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-02 · NCT07501507 · CT.gov ↗
What to watch
Phase 4Idiopathic Granulomatous MastitisNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-02-01 · NCT06943482 · CT.gov ↗
What to watch
March 2028 (5)
Phase 2Osteosarcoma, MetastasisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-03 · NCT07477457 · CT.gov ↗
What to watch
Phase 3Rheumatoid ArthritisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-03 · NCT03414502 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-03-01 · NCT04747912 · CT.gov ↗
What to watch
Phase 1Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Myelodysplastic Syndrome, Recurrent Juvenile Myelomonocytic Leukemia …RecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-03-31 · NCT06247787 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-03-31 · NCT03286634 · CT.gov ↗
What to watch
April 2028 (1)
Phase 1Primary Central Nervous System LymphomaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-04-28 · NCT06541665 · CT.gov ↗
What to watch
May 2028 (3)
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-05 · NCT06533748 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-05-31 · NCT07643103 · CT.gov ↗
What to watch
Phase 2Non-hodgkin LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-05-31 · NCT05998642 · CT.gov ↗
What to watch
June 2028 (3)
Phase 2Acute Myeloid Leukemia in ChildrenRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-06 · NCT06262438 · CT.gov ↗
What to watch
Phase 3Primary Central Nervous System LymphomaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-06 · NCT04931368 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-06-30 · NCT04546399 · CT.gov ↗
What to watch
July 2028 (4)
Phase 1Muscle Invasive Bladder Urothelial CarcinomaEnrolling by invitationStudy of the molecule, not a specific product
Est. primary completion 2028-07-01 · NCT06204614 · CT.gov ↗
What to watch
Phase 3Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-07-01 · NCT04530565 · CT.gov ↗
What to watch
Phase 1Acute Lymphoblastic LeukemiaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-07-02 · NCT05292664 · CT.gov ↗
What to watch
Phase 3Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-07-14 · NCT03643276 · CT.gov ↗
What to watch
August 2028 (4)
Phase 2Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative DisordersRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-08 · NCT06265584 · CT.gov ↗
What to watch
Early phase / not applicablePrimary Central Nervous System Lymphoma, Diffuse Large B-Cell LymphomaNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-08 · NCT07764601 · CT.gov ↗
What to watch
Phase 2Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine, Doxorubicin, Cisplatin, GemcitabineRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-08-30 · NCT06960577 · CT.gov ↗
What to watch
Phase 2Urothelial Carcinoma, Bladder CancerActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-08-31 · NCT05137262 · CT.gov ↗
What to watch
September 2028 (2)
Phase 2Pirtobrutinib, Immunochemotherapy, DLBCL - Diffuse Large B Cell Lymphoma, CNS Involvement of Systemic LymphomaNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-09-01 · NCT07812493 · CT.gov ↗
What to watch
Phase 2/3Primary Central Nervous System LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-09-30 · NCT07185373 · CT.gov ↗
What to watch
October 2028 (2)
Phase 1Acute Lymphoblastic LeukemiaNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-10-13 · NCT07914166 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-10-31 · NCT00501826 · CT.gov ↗
What to watch
November 2028 (1)
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-11-01 · NCT02877303 · CT.gov ↗
What to watch
December 2028 (10)
Phase 1/2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-12 · NCT05848687 · CT.gov ↗
What to watch
Phase 2Proliferative Vitreoretinopathy, Rhegmatogenous Retinal DetachmentRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-12 · NCT06541574 · CT.gov ↗
What to watch
Phase 2Osteosarcoma in Children, Osteosarcoma in Adolescents and Young AdultsRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-12 · NCT07560826 · CT.gov ↗
What to watch
Phase 2LymphomasRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-12-30 · NCT07002099 · CT.gov ↗
What to watch
Phase 2Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)RecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-12-31 · NCT07410520 · CT.gov ↗
What to watch
Phase 2PCNSL, Primary Central Nervous System LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-12-31 · NCT07350850 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-12-31 · NCT03970096 · CT.gov ↗
What to watch
Phase 2Central Nervous System Lymphoma, Secondary Central Nervous System LymphomaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2028-12-31 · NCT03964090 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-12-31 · NCT07301138 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2028-12-31 · NCT06317662 · CT.gov ↗
What to watch
2029 (8)
March 2029 (2)
Phase 1Multiple MyelomaActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2029-03 · NCT04960579 · CT.gov ↗
What to watch
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2029-03-30 · NCT06918431 · CT.gov ↗
What to watch
May 2029 (2)
Phase 4Rheumatoid ArthritisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2029-05-01 · NCT07802678 · CT.gov ↗
What to watch
Phase 2/3Rheumatoid ArthritisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2029-05-31 · NCT07627893 · CT.gov ↗
What to watch
June 2029 (1)
Phase 3Acute Myeloid LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2029-06-30 · NCT04293562 · CT.gov ↗
What to watch
August 2029 (1)
Phase 2Metastatic Oral Cavity Carcinoma, Recurrent Oral Cavity Carcinoma, Stage IVC Lip and Oral Cavity Cancer AJCC v8, Head and Neck Cancer …RecruitingStudy of the molecule, not a specific product
Est. primary completion 2029-08-05 · NCT06997068 · CT.gov ↗
What to watch
October 2029 (1)
Phase 2Graft Versus Host Disease, Hematologic MalignancyRecruitingStudy of the molecule, not a specific product
Est. primary completion 2029-10-18 · NCT06252870 · CT.gov ↗
What to watch
December 2029 (1)
Phase 2Leukemia, Myeloid, AcuteNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2029-12-31 · NCT07686107 · CT.gov ↗
What to watch
2030 (11)
March 2030 (1)
Phase 2B Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2030-03 · NCT06336395 · CT.gov ↗
What to watch
April 2030 (2)
Phase 3Lymphoblastic Lymphoma, ChildhoodRecruitingStudy of the molecule, not a specific product
Est. primary completion 2030-04-22 · NCT04043494 · CT.gov ↗
What to watch
Phase 1CNS LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2030-04-30 · NCT06730542 · CT.gov ↗
What to watch
June 2030 (2)
Phase 4Psoriasis, Atopic DermatitisNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2030-06-01 · NCT07352566 · CT.gov ↗
What to watch
Phase 2/3Mature B-cell Non-Hodgkin LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2030-06-30 · NCT07168980 · CT.gov ↗
What to watch
July 2030 (1)
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2030-07-31 · NCT07227584 · CT.gov ↗
What to watch
August 2030 (1)
Phase 2Adenocarcinoma of the Breast, Breast Cancer, Triple Negative Breast CancerRecruitingStudy of the molecule, not a specific product
Est. primary completion 2030-08-11 · NCT07768436 · CT.gov ↗
What to watch
September 2030 (1)
Phase 2Myelodysplastic/Myeloproliferative Neoplasm, Primary Myelofibrosis, Secondary MyelofibrosisRecruitingStudy of the molecule, not a specific product
Est. primary completion 2030-09-01 · NCT07228624 · CT.gov ↗
What to watch
October 2030 (1)
Phase 2MedulloblastomaNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2030-10 · NCT07856069 · CT.gov ↗
What to watch
November 2030 (1)
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2030-11-22 · NCT06128070 · CT.gov ↗
What to watch
December 2030 (1)
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2030-12-01 · NCT06124157 · CT.gov ↗
What to watch
2031 (5)
January 2031 (1)
Phase 3Graft-versus-host Disease (GVHD)RecruitingStudy of the molecule, not a specific product
Est. primary completion 2031-01-17 · NCT06615050 · CT.gov ↗
What to watch
April 2031 (1)
Phase 2Acute Lymphoblastic LeukemiaNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2031-04-16 · NCT07636564 · CT.gov ↗
What to watch
June 2031 (1)
Phase 2Osteosarcoma, Ewing SarcomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2031-06-01 · NCT07321912 · CT.gov ↗
What to watch
November 2031 (1)
Phase 2/3Langerhans Cell HistiocytosisActive not recruitingStudy of the molecule, not a specific product
Est. primary completion 2031-11 · NCT02205762 · CT.gov ↗
What to watch
December 2031 (1)
Phase 3Extranodal NK/T-cell LymphomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2031-12-31 · NCT07678229 · CT.gov ↗
What to watch
2032 (1)
March 2032 (1)
Phase 3Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2032-03-31 · NCT03959085 · CT.gov ↗
What to watch
2033 (3)
September 2033 (1)
Phase 1/2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2033-09-19 · NCT07387926 · CT.gov ↗
What to watch
November 2033 (1)
Phase 2/3Recurrent Burkitt Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements, Refractory Burkitt Lymphoma …RecruitingStudy of the molecule, not a specific product
Est. primary completion 2033-11-01 · NCT07724457 · CT.gov ↗
What to watch
December 2033 (1)
Phase 2Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2033-12-31 · NCT06099366 · CT.gov ↗
What to watch
2034 (2)
May 2034 (1)
Phase 4Acute Lymphoblastic LeukemiaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2034-05 · NCT06289673 · CT.gov ↗
What to watch
September 2034 (1)
Phase 2Breast CancerRecruitingStudy of the molecule, not a specific product
Est. primary completion 2034-09 · NCT06085742 · CT.gov ↗
What to watch
2035 (2)
July 2035 (1)
Phase 2MedulloblastomaRecruitingStudy of the molecule, not a specific product
Est. primary completion 2035-07 · NCT05535166 · CT.gov ↗
What to watch
September 2035 (1)
Phase 2/3Acute Lymphoblastic LeukemiaNot yet recruitingStudy of the molecule, not a specific product
Est. primary completion 2035-09-01 · NCT07072585 · CT.gov ↗
What to watch
2038 (1)
December 2038 (1)
Phase 2Metastatic Colorectal CancerRecruitingStudy of the molecule, not a specific product
Est. primary completion 2038-12-31 · NCT05725200 · CT.gov ↗
What to watch

See the full readout calendar ↗